DSS, Inc.'s Form 4 filing
Impact Biomedical Inc. (IBO) · filed May 27, 2025
- Accession no.
- 0001641172-25-012502
- Filed
- May 27, 2025
- Trade date
- May 22-27, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $88.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DSS, Inc.CIK 0000771999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2025 | Common Stock | SSaleDisposed | −115,600 | $0.55 | −$63,580 | 45,400 | Direct | |
| May 27, 2025 | Common Stock | SSaleDisposed | −45,400 | $0.54 | −$24,516 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.